Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohamad Akhtar
Exploring Novel Pharmacotherapeutic Applications and Repurposing Potential of Sodium Glucose CoTransporter 2 (SGLT2) Inhibitors
Clinical and Experimental Pharmacology and Physiology
Physiology
Pharmacology
Related publications
Erratum To: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Cardiology and Therapy
Clinical Influence of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors for Cardiovascular and Renal Points of View
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research
Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
European Cardiology Review
Cardiovascular Medicine
Cardiology
Sodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells
PLoS ONE
Multidisciplinary